1, 2, 4‐Triazole‐3‐thione Compounds as Inhibitors of Dizinc Metallo‐β‐lactamases. (12th June 2017)
- Record Type:
- Journal Article
- Title:
- 1, 2, 4‐Triazole‐3‐thione Compounds as Inhibitors of Dizinc Metallo‐β‐lactamases. (12th June 2017)
- Main Title:
- 1, 2, 4‐Triazole‐3‐thione Compounds as Inhibitors of Dizinc Metallo‐β‐lactamases
- Authors:
- Sevaille, Laurent
Gavara, Laurent
Bebrone, Carine
De Luca, Filomena
Nauton, Lionel
Achard, Maud
Mercuri, Paola
Tanfoni, Silvia
Borgianni, Luisa
Guyon, Carole
Lonjon, Pauline
Turan‐Zitouni, Gülhan
Dzieciolowski, Julia
Becker, Katja
Bénard, Lionel
Condon, Ciaran
Maillard, Ludovic
Martinez, Jean
Frère, Jean‐Marie
Dideberg, Otto
Galleni, Moreno
Docquier, Jean‐Denis
Hernandez, Jean‐François - Abstract:
- Abstract: Metallo‐β‐lactamases (MBLs) cause resistance of Gram‐negative bacteria to β‐lactam antibiotics and are of serious concern, because they can inactivate the last‐resort carbapenems and because MBL inhibitors of clinical value are still lacking. We previously identified the original binding mode of 4‐amino‐2, 4‐dihydro‐5‐(2‐methylphenyl)‐3 H ‐1, 2, 4‐triazole‐3‐thione (compound IIIA) within the dizinc active site of the L1 MBL. Herein we present the crystallographic structure of a complex of L1 with the corresponding non‐amino compound IIIB (1, 2‐dihydro‐5‐(2‐methylphenyl)‐3 H ‐1, 2, 4‐triazole‐3‐thione). Unexpectedly, the binding mode of IIIB was similar but reverse to that of IIIA. The 3 D structures suggested that the triazole–thione scaffold was suitable to bind to the catalytic site of dizinc metalloenzymes. On the basis of these results, we synthesized 54 analogues of IIIA or IIIB. Nineteen showed IC50 values in the micromolar range toward at least one of five representative MBLs (i.e., L1, VIM‐4, VIM‐2, NDM‐1, and IMP‐1). Five of these exhibited a significant inhibition of at least four enzymes, including NDM‐1, VIM‐2, and IMP‐1. Active compounds mainly featured either halogen or bulky bicyclic aryl substituents. Finally, some compounds were also tested on several microbial dinuclear zinc‐dependent hydrolases belonging to the MBL‐fold superfamily (i.e., endonucleases and glyoxalase II) to explore their activity toward structurally similar but functionallyAbstract: Metallo‐β‐lactamases (MBLs) cause resistance of Gram‐negative bacteria to β‐lactam antibiotics and are of serious concern, because they can inactivate the last‐resort carbapenems and because MBL inhibitors of clinical value are still lacking. We previously identified the original binding mode of 4‐amino‐2, 4‐dihydro‐5‐(2‐methylphenyl)‐3 H ‐1, 2, 4‐triazole‐3‐thione (compound IIIA) within the dizinc active site of the L1 MBL. Herein we present the crystallographic structure of a complex of L1 with the corresponding non‐amino compound IIIB (1, 2‐dihydro‐5‐(2‐methylphenyl)‐3 H ‐1, 2, 4‐triazole‐3‐thione). Unexpectedly, the binding mode of IIIB was similar but reverse to that of IIIA. The 3 D structures suggested that the triazole–thione scaffold was suitable to bind to the catalytic site of dizinc metalloenzymes. On the basis of these results, we synthesized 54 analogues of IIIA or IIIB. Nineteen showed IC50 values in the micromolar range toward at least one of five representative MBLs (i.e., L1, VIM‐4, VIM‐2, NDM‐1, and IMP‐1). Five of these exhibited a significant inhibition of at least four enzymes, including NDM‐1, VIM‐2, and IMP‐1. Active compounds mainly featured either halogen or bulky bicyclic aryl substituents. Finally, some compounds were also tested on several microbial dinuclear zinc‐dependent hydrolases belonging to the MBL‐fold superfamily (i.e., endonucleases and glyoxalase II) to explore their activity toward structurally similar but functionally distinct enzymes. Whereas the bacterial tRNases were not inhibited, the best IC50 values toward plasmodial glyoxalase II were in the 10 μm range. Abstract : Active duty : A series of 1, 2, 4‐triazole‐3‐thiones were synthesized and evaluated on a panel of metallo‐β‐lactamases involved in bacterial resistance. Some of them were found to have IC50 values in the micromolar range toward IMP‐1, NDM‐1, and VIM‐2. Structural requirements for activity are discussed. The crystal structure of L1–IIIB is reported, and the activity on other metalloenzymes belonging to the metallo‐β‐lactamase‐fold superfamily is also evaluated. … (more)
- Is Part Of:
- ChemMedChem. Volume 12:Number 12(2017)
- Journal:
- ChemMedChem
- Issue:
- Volume 12:Number 12(2017)
- Issue Display:
- Volume 12, Issue 12 (2017)
- Year:
- 2017
- Volume:
- 12
- Issue:
- 12
- Issue Sort Value:
- 2017-0012-0012-0000
- Page Start:
- 972
- Page End:
- 985
- Publication Date:
- 2017-06-12
- Subjects:
- antibiotics -- bacterial resistance -- lactams -- metalloenzymes -- nitrogen heterocycles
Pharmaceutical chemistry -- Periodicals
615.19005 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1860-7187 ↗
http://www3.interscience.wiley.com/cgi-bin/jhome/110485305 ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1002/cmdc.201700186 ↗
- Languages:
- English
- ISSNs:
- 1860-7179
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3172.254000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 3.xml